FIREFLY NEUROSCIENCE, INC. (AIFF) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, FIREFLY NEUROSCIENCE, INC.'s filing signal turned positive.

Firefly Neuroscience, Inc. is an artificial intelligence company focused on advancing precision neuroscience by applying AI and large-scale electrophysiological data to provide clinicians with objective insights into brain function. The company has developed the Firefly Platform, a vertically integrated system comprising hardware, software, and data infrastructure that captures standardized EEG and ERP assessments at the point of care. This data is analyzed by a proprietary engine, delivering structured reports to healthcare providers. As of December 31, 2025, its FDA-cleared Evoke System was deployed in over 85 clinical sites across the United States. Firefly operates on a subscription-based commercial model, generating recurring revenue that scales with clinical utilization and simultaneously expands its proprietary database.

Revenue is generated through a subscription-based model for access to the Evoke System, analytics, and reporting platform, with per-scan overage fees for utilization exceeding monthly allotments. Additional revenue streams include equipment sales, rentals, and projects or clinical studies.